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Abstract

Introduction

Scanning electron microscopy (SEM) was
used to elucidate the mechanism of polymer
degradation and drug release in polyanhydride
microspheres . Three different fabrication
methods
solvent
removal,
solvent
evaporation, and hot melt microencapsulation were
used
to
prepare
polyanhydride
microspheres containing a variety of drugs . The
morphology of these microspheres releasing
drug in vitro and in vivo was studied by SEM
and compared with degradation and release
data measured by conventional methods.
Microspheres prepared by the three techniques
were shown to have distinctive morphological
characteristics induced by the nature of the
fabrication method . In addition, SEM analysis
could be used to explain the drug release
profiles and polymer degradation behavior
seen in vitro as well as the in vivo effects of
insulin-loaded microspheres on diabetic rats.
This study has shown SEM to be an important
and powerful tool for analyzing the effects of
microsphere fabrication method on drug
release.

Polyanhydrides are one of the very few
synthetic bioerodible polymers that are being
utilized as implantable substances in humans
(Chasin
et
al.,
1988).
Hydrophobic
polyanhydride slabs have been found to erode
heterogeneously in aqueous media , thereby
displaying surface erosion (Leong et al., 1985) .
This was attributed to a combination of the
very labile anhydride bond and the very
hydrophobic nature of the polyanhydrides
studied. Water cannot easily penetrate into the
hydrophobic polymer matrix, so degradation
occurs principally on the surface, where the
anhydride bonds are hydrolyzed. Although a
slab which displays surface erosion ( Leong et
al., 1985) would be of considerable utility in
controlled drug delivery , this is not always a
desired geometry. In many cases, micro spheres
have been of considerable interest in the
development of controlled release systems and
other applications; in addition, microspheres
that display surface erosion have yet to be
developed.
With this objective in mind, the
overall goal of this work was to develop
polyanhydride microspheres, to characterize
their internal and surface morphology, study
the type of erosion that takes place and
determine the possibility of using them to
release macromolecules such as insulin. In this
study, it is shown that morphological
evaluation of microspheres by SEM is an
important approach in the evaluation of
microencapsulation
techniques,
thereby
resulting in delivery systems that can be
tailored to achieve a variety of desired
characteristics.
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Materials and Methods

(iii) Solvent removal. In this nethod, the
drug is dispersed or dissolved in a solution of
the polymer in a volatile organic solvent like
methylene chloride. This mixture is then
suspended with stirring in an organic oil (such
as silicon oil), forming an emulsion. Unlike
solvent evaporation, however, where the
dispersed solvent is insoluble in the continuous
aqueous phase, the solvent removal technique
allows the slightly oil-soluble volatile solvent to
be slowly extracted into the oil, thus leaving
behind polymer microspheres. This new
method
permits
the
preparation
of
microspheres from polymers with high melting
points, including polymers which were more
hydrophobic than those previously used
(Mathiowitz and Langer, 1987). Microspheres
were prepared unloaded (blank) and with
three different drugs: Zn-insulin (Eli Lilly), acid
orange 8 (Aldrich) and acetylsalicylic acid
(Aldrich).
Scannini: Electron Microscopy
Morphology of polymers was studied on a
scanning electron microscope (ISi Model DS130 and Hitachi S-530) using 15 and 20 kV.
Cross-sections of samples were obtained by
embedding the microspheres in mounting
media (Histo Prep SO-H-75 Frozen Tissue
Embedding Media, Fisher Scientific) and cutting
10 µ m sections at -20°C with a microtome
(International Equipment Company). Samples
for SEM were freeze-dried, mounted on metal
stubs with
double-sided tape, and sputtercoated with gold-palladium under argon gas
(Cold Polaron Instrument ES I 00 was used). The
samples were coated for 30 or 60 seconds (two
pulses of 30 seconds each were given to the
more porous systems; 30 sec coating results in
50 A O gold thickness), using voltage of 2.5 kV
and a current of 18 mA.
In Vitro Dei:radation Studies
Polyanhydride microspheres contarnrng
Zn-insulin or acid orange were separated into
different size ranges using standard sieves
(Newark Wire Cloth Co). Release experiments
were conducted in 10 to 50 ml aliquots of 0.1
M, pH 7.4 phosphate buffer at 37°C in small
columns (Bio-Rad polypropylene Economocolumn, 10 and 50 ml). Gentamicin sulfate
(Sigma) was used as an antibacterial agent in
the buffer at a concentration of 0.05 mg/ml.
The buffer was changed periodically to assure
perfect sink conditions. The polymer erosion
and acid orange release were followed by
measuring the absorbance of the release buffer

Polymer Preparation
Sebacic acid (SA), 1,3-bis(p-carboxyphenoxy)propane (CPP) and 1, 12-dodecanedioic
acid (DD) (Aldrich) were used as monomers in
the synthesis of polyanhydride homopolymers
and copolymers as previously described (Domb
et al., 1987). Copolymers are referred to by
their monomer abbreviations followed by their
molar percentage in the reaction mixture, e.g. a
copolymer of CPP and SA in a 20:80 molar
proportion is termed P(CPP-SA) 20:80.
Molecular weights of synthesized polymers
were measured by gel permeation chromatography as described previously (Domb et al.,
1987); all the polyanhydrides had weight
average molecular weights between 25K and
40K. Infrared spectroscopy (film cast onto NaCl
plates) of all the polymers revealed typical
anhydride absorbances at 1720 and 1780 cm- 1 .
Microsphere Preparation
Micro spheres were prepared using three
encapsulation methods:
(i) Solvent evaporation. In this method
the polymer is dissolved in a volatile organic
solvent, the drug (either soluble or dispersed as
fine particles) is added to the solution, and the
mixture is suspended in an aqueous solution
that contains a surface active agent such as
poly(vinyl alcohol) . The resulting emulsion is
stirred until most of the organic solvent
evaporates, leaving solid microspheres (Beck et
al., 1979; Benita et al., I 984; Jaffe H., 1981) In
the present work the method was used with
the following modifications: the polyanhydride
P(CPP -SA) 50:50 was dissolved in methylene
chloride. Two different polymer concentrations
were used (0.05 and 0.20 g/ml). The solution
was loaded with drug and suspended in 200 ml
of vigorously stirring distilled water containing
1% (w/v) poly(vinyl alcohol) (Sigma) . After 4
hours of mixing, the microspheres were washed
with water and dried overnight in a lyophilizer.
(ii) Hot melt microencapsulation. In this
method the polymer is first melted and then
mixed with the solid particles of the dye or
drug that have been sieved to less than 50 µm
(Mathiowitz and Langer, 1987). The mixture is
suspended in a non-miscible solvent (like
silicon oil) that is heated 5°C above the melting
point of the polymer and stirred continuously.
Once the emulsion is stabilized, it is cooled until
the
polymer
particles
solidify.
The
microspheres are washed by decantation with
petroleum ether to give free-flowing powders .
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at 490 nm for the acid orange and at 247 nm
for the polymer erosion products (Mathiowitz
and Langer, 1987) with a Perkin-Elmer UV
spectrophotometer. An in vitro Bio-rad protein
assay was employed to measure insulin
concentrations
in
the
release
buffer
(Mathiowitz et al., 1988).
In Vivo Studies With Diabetic Rats
Biological activity of insulin released from
microspheres was determined in vivo by
monitoring daily blood and urine glucose levels
in polymer-implanted diabetic female SpragueDawley rats. Diabetes was previously induced
with a tail vein injection of 65 mg/kg of
streptozotocin (Upjohn) in pH 4.5, O. lM citrate
buffer, the optimal dose for inducing diabetes
in these rats (Brown et al., 1983). When serum
glucose levels reached a minimum of 400
mg/di the rats were considered diabetic and
were
treated
with
the
insulin-loaded
polyanhydride microspheres. Daily urine
glucose
outputs
were
estimated
with
Chemstrips UG (Bio-Dynamics) . Blood was
drawn daily from the tail vein and serum
glucose levels were read on a YSI Model 23A
Glucose Analyzer.
Dry
microspheres
were
implanted
subcutaneously through a small (1 cm) surgical
incision in the skin of the dorsum of the rat and
the skin was closed with 5-0 Ethilon
monofilament nylon sutures (Ethicon). Where
indicated, certain microspheres were injected
in an aqueous suspension in 0.1 M pH 7.4
phosphate buffer through a 22 gauge needle
(bigger microspheres were implanted). Three
groups were studied: healthy rats, diabetic
control rats
and diabetic rats that were
implanted with the drug- loaded spheres.
In Vivo De1:radatioo Studies
In vivo degradation
studies
were
performed after implanting or injecting blank
microspheres as described above. Rats were
sacrificed sequentially on days 6, 10 and 46 by
CO2 overdose. Microspheres were isolated from
tissue samples, the polymer itself was freeze
dried, lyophilized, cross-sectioned with a blade,
coated with gold and analyzed by SEM as
described before.

Rl, R2 could be any of the following:

n=8 Sebacic acid (SA)
n= 10 Dodecanedioic acid (DD)

-OO-(CH2),-0-0
(p-Carboxyphenoxy)propane (CPP)
Figure 1. Chemical structure of polyanhydrides.
polyanhydrides used in this study are shown in
Figure 1. They are composed of aliphatic
monomers, such as sebacic acid, and aromatic
monomers, such as CPP. Homopolymers of the
aliphatic monomers degrade rapidly (1 to 6
days depending on the size of the device), are
soluble in organic solvents (Mathiowitz et al.,
1988), have low melting points (Domb et al.,
1987) and glass transition at 60°C (Mathiowitz
et al, 1989), and their degradation products
have good solubility in aqueous solutions
(Mathiowitz et al., 1988). Polymers made of
aromatic monomers (Figure 1) degrade much
more slowly (weeks to years), are insoluble in
organic solvents (Mathiowitz et al., 1988), have
high melting points (Domb et al., 1987) and
glass transition at 96°C (Conix, 1958) and their
degradation products have low aqueous
solubility. Copolymers made of aliphatic and
aromatic monomers
degrade in aqueous
enviroments in times that range from one day
to several weeks, are soluble in organic
solvents (Mathiowitz et al., 1988), and their
melting point and the solubility of the
degradation products depends on the ratio of
the aliphatic to aromatic monomers. The glass
transition temperatures for the P(CPP-SA)
20:80 and the P(CPP-SA) 50:50 copolymers are
47°C and 2°C respectively (Mathiowitz et al,
1989). These are random polymers when the
ratio of monomer is 1: 1 and the polymers tend
to display block type distributions when either
of the monomers is in excess (Ron et al, 1988).
The polymers are semicrystalline with degrees
of crystallinity ranging from 5 to 60%

Results And Discussion
Polymer Characteristics
The first step in the development of any
type of delivery system is
understanding the
physical properties of the polymer from which
it is formed. Chemical structures of the various
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(Mathiowitz et al,
1988) . The various
microencapsulation processes which were
developed and/or employed were designed to
address all these physical properties in such a
way as to enable microspheres to be produced
given nearly any polymer property and
monomer composition.

In Vitro And In Vivo Morphological Studies Of
Polyanhydride Microspheres
a} Poiyanhydride microspheres prepared
by the solvent evaporation technique. One of
the oldest and most widely used methods of
microsphere
preparation
is
the
solvent
evaporation technique .
Figure 2a is an SEM
micrograph of the external surface of a P(CPPSA) 50: 50 polymer microsphere containing 5%
(w/w) insulin. For this particular fabrication
the initial polymer concentration was 0.05
gr/ml of methylene chloride. The microspheres
are spherical in shape and contain some pores
on the surface (Figure 2b); a cross-sectional
view of the microsphere reveals a very porous
internal structure (Figure 2c) which is typical
of this particular process. Porosity can be
varied by changing the rate of solvent
evaporation (via the temperature or stunng
rate) as well as the concentration of the initial
polymer solution. When the fabrication was
repeated as above with an initial polymer
concentration of 0 .20 g/ml of methylene
chloride, the resulting microspheres showed a
marked drop in porosity.
In Vivo release . The microspheres were
implanted inside diabetic rats and the blood
glucose level was lowered precipitously for one
day, with the majority of the rats dying due to
insulin overdose. The
porous structure of the
spheres would allow water to enter the sphere
quickly and lead to complete insulin release in
a short period of time, which may explain the
extremely
fast
and
generally
fatal
hypoglycemia that was observed.
Besides resulting in high microsphere
porosity, sol vent evaporation also accelerates
polymer degradation during the first stages of
preparation due to the presence of the water
phase . For these reasons, other fabrication
methods to make slower-releasing and longeractive
polyanhydride
microspheres
were
developed .

Figure 2. a) External surface of P(CPP-SA)
50:50
micro spheres
made
by
solvent
evaporation.
Polymer
concentration
in
methylene chloride was 0.05 g/ml. Size of
microspheres was 100-200 µm. Bar=lO0 µm b)
Higher magnification of a) revealing small
pores in the external surface. Bar= 10 µm . c)
Cross-section of the same microspheres
revealing a very porous structure in the center
and more dense structure close to the external
surface. Bar= 50 µm
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b) Polyanhydride microspheres prepared
by hot melt microencapsulation: In this method
we used polymer which had a relatively low
melting point: P(CPP-SA) 20:80. Since in some
cases the drug tends to precipitate on the
external surface of the microspheres during the
fabrication process, an external analysis of
drug-loaded microspheres was very important.
Figure 3a,b is an example of a P(CPP-SA) 20:80
microsphere
loaded
with
40%
(w / w)
acetylsalicylic acid. As can be seen, some of the
drug particles coat the external surface of the
microsphere. This type of microsphere could be
useful if pulsatile release is needed, i.e., one
would presumably obtain initially a fast, burstlike dissolution of the external drug followed
by the slower diffusional release of the internal
drug . However, in most cases it is necessary to
avoid the burst effect for reasons of toxicity ,
and this can be done by using small drug
particle sizes as well as lower drug loadings.
When 15 % (w/w) loaded microspheres were
prepared, using acetylsalicylic acid (or insulin)
sieved to less than 50 µm, no sign of drug was
observed on the external surface (Figure 4a).
Microspheres obtained from this polymer by
hot melt microencapsulation were spherical in
shape (Figure 4a) . The external surface of these
microspheres is dense and crenelated which is
typical of the hot melt microencapsulation
method (Figure 4a,b).
In vitro release . Both blank and drugloaded microspheres prepared by hot melt
microencapsulation were analyzed by SEM
after in vitro degradation as described in
Materials and Methods. The microspheres
retained their structural integrity for only
about 4 to 5 days. Cross-sections of the
microspheres before degradation (Figure 4b)
revealed a dense structure with a slightly more
dense region at the surface. A cross-section of
the microspheres after 15 hours (Figure 4c)
showed a dense internal core surrounded by a
well-defined erosion zone. This erosion zone
advances, with time, from the outer surface of
the device inwards . Measurement of the
molecular weight distribution of the polymer
during the first 2 days of degradation indicated
that the internal core indeed consisted of
unhydrolyzed polymer (Mathiowitz and Langer,
1987). After 6 to 10 days of degradation, the
microspheres
tended
to
break
apart
completely. However, with care it was possible
to remove isolated, fragile microspheres similar
to the one shown in Figure 4d. Microspheres
sampled at this time were only 3 to 5% of their

Figure 3. a) External surface of P(CPP-SA)
20:80 microspheres, made by hot melt
microencapsulation and loaded with 40% (w/w)
acetylsalicylic acid Crystals on the surface are
the drug particles (acetylsalicylic acid) that
were not incorporated in the microsphere. Bar=
2 0 0 µ m. b) The same as a) but higher
magnification showing the crystals close to the
polymer external surface. Bar= 10 µm .
initial weight and when cross-sectioned (Figure
4e) a very porous and brittle structure was
observed . Analysis of the remains by infra red
spectroscopy showed that the microspheres
consisted of polymer degradation products that
eventually disappeared in vitro at longer times.
All of these results strongly indicate that the
release process is dominated by surface
erosion.
The
drug
release
and
polymer
degradation results from these in vitro studies
supply further evidence supporting surface
erosion as the controlling mechanism for
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Figure 4. SEM of a P(CPP-SA) 20:80
micro sphere
made
by
hot
melt
microencapsulation. a) External surface of
insulin loaded microspheres(l 5 %loading). (From
Mathiowitz E, Langer R. (1987). Journal of
Controlled Release. .5.., 13-22. With permission)
Note the smooth butcrenelated
external
surface. Bar= 50 µm. b) Cross-section of blank
microsphere before degradation. Note the
dense internal structure . Bar= 100 µm. c) cross
section of blank microsphere, 15 hr after start
of degradation. A well-defined eroding zone
exist which surrounds an internal intact zone.
Bar= l00µm. d) External surface of blank
microsphere 10 days after degradation. Bar=
l0Oµm. e) Cross-section of a sphere 10 days
after degradation. Note the fragile structure
which is composed only of monomeric
degradation products. Bar=500µm.
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• Acid Orange 27 %
Polymer 27%
o Aci d Orange 2 %
o Poly mer 2%

■

25
Time (hours}

50

Figure 5 .
Pol ymer degrad ation and acid
o range
release
from
P(CPP-SA)20 : 80
micro sphere s
made
by
hot
melt
microencapsulation (size: 800-1 ,000µm) for
both 2% and 27% (w/ w) loadings . (From
Mathiowitz E , Langer R.(1987) . Journal of
Controlled Release 5.., 13 22. With permiss ion)

Figure 6. Cross-section of
P(CPP-SA) 20: 80
micro sphere
(made
by
hot
melt
microencapsulation) after 6 day s of in viv o
degradation. Note the porous internal structure
and the dense structure near the external
surface . Bar= lO0µm.
melt
microencapsulation were implante d
subcutaneously in rats . These we re relatively
large micro spheres ranging from 800 to 1000
µm in diameter. Tissue samples of the
implantation
site
were
removed
at
predetermined times. Since the larger P(CPPSA) 20:80 microsphere s could be easily
removed from the tis sue , one of them wa s
taken from the day 6 sample and analysed by
SEM. It was still spherical in shape, although
very soft, and weighed only 6% of its initial
weight. The sphere was freeze-dried and crosssectioned for analysis , which caused it to
collapse from its original spherical shape. The
cross-sectional view is shown in Figure 6. The
external surface of the sphere, which directly
interacted with the living tissue, seems to be
similar to that obtained for blank microspheres
degrading in vitro (Figure 4c), while the
material from the inner core has already been
degraded. It is important to note that
microspheres that were taken out of the tissue
one or 2 days after implantation still contained
an intact core, as was also found in the in vitro
studies.
Furthermore,
the
micro spheres
disappeared completely in vivo at longer times,
as they did in vitro.
In vivo release. The effect of a less
porous internal morphology on release profiles
was also seen in vivo . When P(CPP-SA) 20:80

release from microsphere s made by hot melt
microencap sulation . The relation between
polymer degradation and drug release in these
micro spheres was a strong function of the drug
loading (Figure 5) . When low loadings (-2%) of
very hydrophilic drugs such as acid orange
were used (Figure 5) , the drug relea se and
polymer erosion profiles were very similar,
which was characteristic of release controlled
by surface erosion . The explanation for this
behavior was as follows : at low loading each
drug particle was completely surrounded by
polymer, so drug dissolution and release was
not possible until the surrounding polymer has
been degraded . As drug loading was increased,
the particles were no longer isolated but
instead formed a connected network of pores
through which water could enter and dissolve
the drug. As the results for 27% loaded devices
in Figure 5 demonstrate, release at high drug
loadings was controlled by diffusion through
the drug-formed pores in the microsphere
(Saltzman et al., 1987), rather then release due
to erosion of the surrounding polymer. When
more hydrophobic drugs , such as Zn-insulin,
were incorporated, a nice correlation between
drug release and polymer ewsion occurred
(Mathiowitz and Langer, 1987).
In Vivo de~radation. Blank microspheres
composed of P(CPP-SA) 20:80 and made by hot
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a

microcapsules loaded with 15% (w/w) Zninsulin
were
prepared
by
hot
melt
microencapsulation and implanted into diabetic
rats, normoglycemia was achieved for 3-4 days
(Figure 7a-b) with no deaths due to insulin
overdose. This stands in stark contrast to the
microspheres made by solvent evaporation,
which
caused
short-lived,
often
fatal
hypoglycemia .
While the hot melt fabrication method
has certain advantages as demonstrated by in
vivo and SEM analysis, many drugs lose
biological act1v1ty at high temperature.
Therefore, this technique can only be used with
low melting point polymers. This fact
encouraged us to develop a less drastic method
which is similar to solvent evaporation but
lacks the aqueous phase which initiates
polymer hydrolysis .
c) Polyanhydride microspheres prepared
by solvent removal: This method, based on
sol vent evaporation, offers several significant
advantages
over
previously
discussed
fabrication techniques, i.e ., the process occurs
at room temperature and in the complete
absence of water. The latter advantage is
particularly important for hydrolytically labile
polymers such as polyanhydrides. Copolymers
of CPP copolymerized with sebacic acid or
dodecanedioic acid (DD) at a molar ratio of
50:50 were used for this method. In general,
the microspheres were spherical in shape
(Figure 8) with a dense outer surface but a
porous internal structure (see for example
Figure 9). The P(CPP-SA) 50:50 microspheres
(Figure 9) displayed slight porosity, whereas
the porosity of the P(CPP-DD) 50:50 spheres
was significantly lower (Mathiowitz et al.,
1988).
The formation of a porous structure
inside and a dense structure outside may be
due to precipitation occurring first on the outer
surface of the sphere during fabrication. Once
the external surface precipitates, the internal
core still contains methylene chloride; from
that stage on, no decrease in the microsphere
size or shrinking of the structure will occur,
even as the remaining solvent diffuses out.
In vivo
degradation. Blank P(CPP-SA)
50:50 microspheres prepared by solvent
removal were implanted subcutaneously in
rats. The spheres were smaller then 300 µm
and were thus injected as an aqueous
suspension. After 10 days of implantation
several spherical microsphere remnants
were
found among the remains of degraded
microspheres in tissue samples taken from the
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Figure 7. Urine (a) and blood (b) glucose
levels of diabetic rats either untreated (control)
or implanted with insulin-loaded P(CPP-SA)
20:80 microspheres on the 4th and 2nd days
(treated). Microspheres were made by the hot
melt technique with an insulin loading of 15%
(w/w). Size of microspheres: 800-1000 µm.
Control animals were diabetic rats. (From
Mathiowitz E, Langer R. (1987). Journal of
Controlled Release .5.., 13-22. With permission)
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Figure 9. Cross-section
of
the
same
microspheres as in Figure 8. Bar= 50 µm.(From
Mathiowitz et al. (1988). Journal of Applied
Polymer
Sciences
l i, 755-774. With
permission). Note the semi porous structure in
the core compared to the denser structure near
the external surface

Figure 8.
SEM of external surface of P(CPPSA) 50:50 microspheres made by solvent
removal technique. Note the dense external
surface of the microspheres. Bar= IO µm.

implantation site. These remnants were
composed of the same polymer degradation
products as seen in the non-intact remnants (as
judged by IR spectroscopy) and eventually
disappeared from the implantation area. As
previously noted , spherical remnants of the
external surface were also seen in vivo with
degrading blank microspheres made by the hot
melt microencapsulation method.
Although the appearance of external
remnants might, at first glance, appear to
contradict other evidence supporting surface
erosion, the SEM analysis of microspheres
already
presented
suggests
a
possible
explanation based on polymer density. Crosssections of microspheres during release (Figure
4b) show an outer zone in which degradation
has already occurred but the degradation
products have not yet disappeared. In addition,
cross-sectional
views
of
undegraded
microspheres made by both solvent removal
(Figure 9) and hot melt microencapsulation
(Figure 4a) show a dense external surface and a
less dense inner core. It is quite plausible that
during degradation the external surface erodes
completely, leaving behind a dense but
permeable layer of degradation products that
must dissolve and diffuse away. Meanwhile,
erosion continues into the core, where the
degraded material is less dense and is able to
more easily solubilize and diffuse out. The fact

that the remnants disappear at longer times in
vivo is further evidence that solubilization of
the degradation
products
may
be
the
controlling step in the disappearance of the
microspheres, but Il.Q.1_ in the release of the
drug.
In vivo release. An in vivo study with
insulin-loaded microspheres prepared by the
solvent removal method demonstrated serum
and urine glucose control much more successful
than that previously seen with
microspheres
made by sol vent evaporation.
Five diabetic
rats were implanted with 200 mg of
microspheres containing insulin at a 10% (w/w)
loading.
As the results in Figure 10
demonstrate, five days of near-zero unne
glucose levels and four days of serum glucose
control were achieved. A similar experiment
with 200 mg of 5% (w/w) loaded microspheres
decreased urine glucose effectively for three
days and resulted rn only one day of
normoglycemia, while 100 mg of 10% (w/w)
loaded microspheres showed three days of
lowered urine glucose and two days of serum
glucose control. For comparison, urine and
blood glucose levels for both diabetic control
and healthy control rats (five rats in each
group) were measured. As expected, glucose
was never found in the urine of healthy rats,
and the untreated diabetic rats showed no
significant lowering of blood or urine glucose
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near normal serum gluco se levels for four days.
In comparison , the in vitro re sult s showed five
to six day s of insulin release (Figure 11 ). In a
s imilar
s et
of
studi es,
in sulin-loaded
micro spheres prepared by solvent removal
cau sed a longer -lasting normoglycemia than
c orre s ponding
hot
melt
micro s pheres
(Mathiowitz and Langer, 1987) , even though
the former were much smaller (less than 300
µm) and would be expected to release insulin
more quickly . This may be explained by the
fact that the micro spheres prepared by solvent
removal were made of a more hydrophobic
polymer which degraded more slowly.
d) General comments. The in vivo
treatments discussed above are limited to a
short term release of insulin, that is, periods of
time that range between one day and one
week. However , even this can be an
improvement over a daily injection of in sulin
required by many diabetic patients. Longer
insulin delivery times can presumably be
achieved by using polymers which are more
hydrophobic and more crystalline.
The advantage of the several fabrication
methods described is that they allow polymers
and drugs of widely varying physical
properties to be used to make microspheres.
The hot melt method is carried out close to the
polymer melting point, which limits it to low

/ 0

0

0

O

Figure 11. Insulin released from P(CPP-SA)
50:50 microspheres, 10% (w / w) loading
prepared
by
s ol vent
removal.
(From
Mathiowitz et al. ( 1988). Journal of Applied
Polymer
Sci e nces
l i, 755-774 . With
permission)
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Figure 10. Blood (a) and urine (b) gluc ose
levels of diabetic rats implanted with 10 %
(w / w) Zn-insulin-loaded P(CPP-SA) 50:50
microspheres (sol vent removal method) on day
0 ; size of microspheres was 50-300 µm . (From
Mathiowitz et al. (1988). Journal of Applied
Polymer
Sciences
l l , 755-774 . With
permission)
levels

(Figure 10).
vitro release. In addition, the 10%
(w /w) loaded microspheres show a good
correlation between the 1n vivo glucose
measurements discussed in the previous
paragraph and in vitro release results . This
system resulted in a decrease in urine glucose
levels to near-zero levels for five days and
In
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melting point polymers; however, the great
advantage of this method is the elimination of
organic solvents that may inactivate protein
drugs. The solvent removal technique, although
carried out in organic sol vents, provides for
room temperature microsphere formation for
polymers of any melting point without
hydrolytic degradation of the polymer or
dissolution of water soluble drug. Solvent
evaporation, though not useful here because of
the hydrolytic instability of polyanhydrides, is
applicable for more stable polymers in which
lipophilic drugs are being incorporated.

Chasin M, Lewis D, Langer R. (1988).
Polyanhydrides for controlled drug delivery.
Biopharm Manufacturing L 33-46.
Conix A.(1958) Aromatic polyanhydrides; a
new class of high melting fiber-forming
polymers. J. Polymer Sci. 29 . 343-351.
Domb A, Langer R. (1987) . Polyanhydrides .
I. Preparation of high molecular weight
polyanhydrides. J. Polymer. Sci. 25, 3373-3386.
Jaffe H. (1981 ). Microencapsulation process,
U. S. Patent 4, 272, 398, June 9.

Summary

Leong KW,
Brott BC, Langer R. (1985).
Bioerodible polyanhydrides as drug carrier
matrices. I : Characterization, degradation, and
drug release characteristics. J. Biom . Mat. Res.
1..2., 941-955.

The goal of this paper was to show that by
the judicious use of SEM in conjunction with
conventional release studies, an understanding
of how to achieve well-defined delivery
systems suitable for a given polymer/drug pair
can be obtained. Although this study was
confined to the development of a continuous,
short-term
drug
delivery
system,
the
applicability of SEM analysis can be envisioned
for other desired release profiles, e.g. systems
that display a pulsatile release . Alternating
shells of fast and slow degrading polymer in a
microsphere might be a way to achieve this
goal, and morphological studies using the
techniques described here are likely to be of
utility in ensuring that the desired degradation
behavior is indeed occurring .

Mathiowitz
E,
Langer
R.
(1987).
Polyanhydride microspheres as drug carriers I.
Hot-melt microencapsulation. J. Controlled
Release .5.., 13-22.
Mathiowitz E, Saltzman WM, Domb A, Dor P,
Langer R. (1988). Polyanhydride microspheres
as drug carriers. II . Micro -e ncapsulation by
solvent removal. J. Appl. Polymer Sci. li, 755774.
Mathiowitz E, Ron E, Mathiowitz G, Amato C,
Langer R. (1989). Surface morphology of
bioerodible
poly(anhydrides).
Polymer
preprints, ill, 460-461. Division of Polymer
Chemistry, ACS P.O. Box 20453. Newark, New
Jersey 07101, USA.

Acknowled2ements
This study was supported by a grant from
NOV A Pharmaceuticals and NIH Grant
1UO1Al25901.

Ron E, Mathiowitz E, Mathiowitz G, Doh L,
Amato C, Langer R.
(1988). "Copolymer
compos1t1on
and
microstructure
of
poly(anhydrides)". Proc. 15th International
Symposium on the Controlled release of
Bioactive Materials, Controlled Release Society,
Basel, Switzerland. 252-253 . The Controlled
Release Society, INC. 16 Nottingham Drive,
Lincolnshire, Illinois 60015, USA .

References
Beck LR, Cowsar DR, Lewis DH, Cosgrove RJ
Jr., Riddle CT, Lowry SL, Epperly T. (1979). A
new long-acting injectable micro -c apsule
system for the administration of progesterone.
Fertil. Steril. 11., 545-551.
Benita S, Benoit JP, Puisieux F, Thies C.
(1984 ). Characterization of drug loaded poly(d,
/-lactide) microspheres. J. Pharm. Sci. 73, 17211724 .

Saltzman WM,
Pasternak SH, Langer R.
(1987). Quantitative image analysis for
developing microstructural descriptions of
heterogeneous materials. Chem. Eng. Sci .
42, 1989-2004.

Brown LR, Wei CL, Langer R. (1983). In vivo
and in vitro release of macromolecules from
polymeric drug delivery systems. J. Pharm. Sci.
72, 1181-1185.
339

E. Mathiowitz, D. Kline, and R. Langer

Tamarago. RJ, Epstein JI, Reinhard CS,
Chaisin M, Brem H. (1989). Biocompatibility of a
biodegradable controlled release polymer in
rats. J. of Biom. Mat. Res., 23, 253-266 .

M.A.
Wheatley: Can you comment on the
relationship between size and degradation
profile?
Authors: As a general rule, if we take the same
preparation method, let's assume hot melt, and
vary only the size of the microspheres, the
degradation of smaller microspheres will be
much faster than that of larger ones. For more
details, the readers are referred to the specific
paper
which
discuss
this
phenomenon
(Mathiowitz and Langer 1987, Mathiowitz et al.,
1988). The purpose of this work was to
demonstrate that
other properties,
like
morphology, are also very important and may
influence degradation rate.

Discussion with Reviewers
A.J.
Wassermann: You suggest 1n the
manuscript that the anhydride bond of the
polyanhydride microsphere is hydrolyzed.
Presumably this occurs post-implantation, 1n
the tissues, and is the mechanism of
microsphere
erosion
and
drug
release.
However, was an inflammatory response
present in the tissue when the microspheres
were removed? Is it possible that phagocytosis
and hydrolytic enzymes of inflammatory cells
contribute
to
microsphere
erosion
and
consequently drug release?
Authors: The mechanism of in vivo erosion of
microspheres
presumably
does
involve
phagocytosis. In a recent work by Tamarago et
al. (1989) this issue was discussed in more
detail (in their case slabs were implanted in the
brains of rats). In our case, preliminary results
do reveal that macrophages are involved in the
process and, of course, they must influence the
polymer degradation in vivo, but more work is
needed to study this phenomenon.
Y. Talmon: What were the criteria for particle
size selection in this study, and how much
control on particle size do the three techniques
give?
Authors: This is a good question. With both hot
melt and solvent evaporation techniques, the
size was determined mostly by the stirring
rate . With these methods, one can form
microspheres ranging from 1 to 1000 microns
in diameter. With the solvent removal method
it was possible to get microspheres smaller
than 300 microns. For more information, the
reader is referred to the two specific papers
which describe the preparation of these
microspheres in more detail (Mathiowitz and
Langer 1987, Mathiowitz et al., 1988).
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